| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/07/1996 | WO1996006941A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle |
| 03/07/1996 | WO1996006860A2 Gradual modification, super-agonists and antagonists of signal-proteins and peptides |
| 03/07/1996 | WO1996006857A1 Immunostimulatory agents |
| 03/07/1996 | WO1996006855A1 NEW PEPTIDE DERIVATIVES WITH δ OPIOID RECEPTOR ANTAGONIST OR MIXED ν AGONIST/δ ANTAGONIST EFFECTS |
| 03/07/1996 | WO1996006630A1 Methods and compositions for modulating a t cell response |
| 03/07/1996 | WO1996006627A1 Mutant enterotoxin effective as a non-toxic oral adjuvant |
| 03/07/1996 | WO1995019777A3 Use of diesters of muramyl peptides in oral form as immunostimulating agents |
| 03/07/1996 | CA2198919A1 Gradual modification, super agonists and antagonists of signs and peptides |
| 03/07/1996 | CA2198891A1 Genetically modified t cells |
| 03/07/1996 | CA2198462A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle |
| 03/07/1996 | CA2197566A1 New peptide derivatives with .delta. opioid receptor antagonist or mixed.mu. agonist/.delta. antagonist effects |
| 03/06/1996 | EP0699674A1 1-Aryl-2-acetylamidopentanone derivatives for use as tachykinin receptor antagonists |
| 03/06/1996 | EP0699665A1 Imidazoline derivatives, their preparation and their use as tachykinin receptor antagonists |
| 03/06/1996 | EP0699442A1 Use of a strain of the fungus fusarium as a substance producer and a preparation based onit with adaptogenic and immunomodulating properties |
| 03/06/1996 | EP0699188A1 Quinoline derivatives as leukotriene antagonists |
| 03/06/1996 | EP0699073A1 Allogeneic and xenogeneic transplantation |
| 03/06/1996 | EP0479899B1 Vasodilatory and immune suppressant peptides |
| 03/06/1996 | CN1118164A Novel 2,2'-BI-1H-pyrrole derivatives with immunosuppressant activity |
| 03/06/1996 | CN1117874A Nasally administrable compositions |
| 03/06/1996 | CN1031193C Polypeptide and method for preparing same |
| 03/05/1996 | US5496832 Method of treating cardiac inflammatory disease |
| 03/05/1996 | US5496727 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
| 03/05/1996 | US5496564 Suspendible composition and process for preparing the same |
| 03/05/1996 | US5496554 Purified mite allergen |
| 02/29/1996 | WO1996006176A1 Functional modified hsv1-tk |
| 02/29/1996 | WO1996006169A1 Human chemokine beta-9 |
| 02/29/1996 | WO1996006107A1 Methods of identifying compounds useful for treating autoimmune diseases |
| 02/29/1996 | WO1996006094A1 Novel substituted piperidines useful for the treatment of allergic diseases |
| 02/29/1996 | WO1996006083A1 2-(piperazinyl-1-carbonylmethyl)-1,4-dihydropyridines as bradykinin antagonists |
| 02/29/1996 | WO1996006082A1 Dihydropyridine derivatives as bradykinin antagonists |
| 02/29/1996 | WO1996006074A1 Metalloproteinase inhibitors |
| 02/29/1996 | WO1996006069A1 D-b-lysylmethanediamine derivatives with bacteria, aids virus and tumor cell growth inhibiting activity and preparation thereof |
| 02/29/1996 | WO1996005863A1 Compounds, pharmaceutical composition and diagnostic device comprising same and their use |
| 02/29/1996 | WO1996005856A1 Human chemokine polypeptides |
| 02/29/1996 | WO1996005838A2 Combined preparation for the therapy of immune diseases |
| 02/29/1996 | WO1996005837A1 Use of n-substituted phenothiazines |
| 02/29/1996 | DE4430128A1 Kombinationspräparat mit immunsuppressiven, kardiovaskulären und cerebralen Wirkungen Combination with immunosuppressive drug, cardiovascular and cerebral effects |
| 02/29/1996 | DE4430091A1 Verwendung von N-substituierten Phenothiazinen Use of N-substituted phenothiazines |
| 02/29/1996 | CA2198256A1 Use of n-substituted phenothiazines |
| 02/29/1996 | CA2198206A1 Human chemokine beta-9 |
| 02/28/1996 | EP0698087A1 Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer |
| 02/28/1996 | EP0698016A1 Novel lupane derivatives, their preparation and pharmaceutical compositions containing same |
| 02/28/1996 | EP0698008A1 Novel lupane derivatives, their preparation and pharmaceutical compositions containing same |
| 02/28/1996 | EP0697891A1 Polyoxime compounds and their preparation |
| 02/28/1996 | EP0697881A1 New cyclosporine-containing pharmaceutical compositions for oral administration |
| 02/28/1996 | EP0697880A1 Inhibition of leukocyte adhesion |
| 02/28/1996 | EP0697876A1 Xenograft thymus |
| 02/28/1996 | EP0697875A1 Use of modified tall-104 cells to treat cancer and viral diseases |
| 02/28/1996 | EP0697873A1 Olefin-substituted long chain compounds |
| 02/28/1996 | EP0697868A1 Methods and compositions using optically pure (+)-zileuton |
| 02/28/1996 | EP0697866A1 High dose formulations |
| 02/28/1996 | CN1031132C Process for preparation of carbocyclic adenosine analogs useful as immunosuppressants |
| 02/27/1996 | US5495043 Substituted di-t-butylphenols |
| 02/27/1996 | US5494907 11-β substituted-19-nor steroids |
| 02/27/1996 | US5494905 Vitamin D amide derivatives |
| 02/27/1996 | US5494820 Streptomyces braegensis strain and its cultivation in a process for producing C9 -desoxo-FK-520 |
| 02/27/1996 | CA2155447A1 Substituted biphenyl isoxazole sulfonamides |
| 02/22/1996 | WO1996005288A2 T cell activation |
| 02/22/1996 | WO1996005228A1 METHOD OF PRODUCING SINGLE-CHAIN Fv MOLECULES |
| 02/22/1996 | WO1996005221A1 Calcitonin receptor |
| 02/22/1996 | WO1996005203A1 Spiro-substituted azacyclic derivatives and their use as therapeutic agents |
| 02/22/1996 | WO1996005193A1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 02/22/1996 | WO1996004932A1 Novel vaccine adjuvant and vaccine |
| 02/22/1996 | WO1996004928A1 Calcitonin gene related peptide receptor |
| 02/22/1996 | WO1996004927A1 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF |
| 02/22/1996 | WO1996004923A1 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides |
| 02/22/1996 | WO1996004913A1 Hiv protease inhibitor combination |
| 02/22/1996 | WO1996001110A3 Anti-hiv triple combination |
| 02/22/1996 | WO1996000068A3 Combination therapy for hiv infection |
| 02/22/1996 | CA2197801A1 T cell activation |
| 02/22/1996 | CA2197232A1 Method of producing single-chain fv molecules |
| 02/22/1996 | CA2197205A1 Methods for treating sepsis or inflammatory diseases with oxypurine nucleosides |
| 02/22/1996 | CA2195757A1 Spiro-substituted azacyclic derivatives and their use as therapeutic agents |
| 02/22/1996 | CA2173727A1 Novel gnrh analogues with antitumour effects and pharmaceutical compositions thereof |
| 02/21/1996 | EP0614455B1 Vitamin d amide derivatives |
| 02/21/1996 | EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha |
| 02/21/1996 | CN1031057C Preparation of triazolo |4,3-a¨|1,4¨ benzodiazepine and thiapheno |3,2-f¨|1,2,4¨ triazolo |4,3-a¨|1,4¨diazepine derivatives |
| 02/21/1996 | CN1031053C Method for preparation of azaoxindole derivatives |
| 02/20/1996 | US5493030 5-substituted derivatives of mycophenolic acid |
| 02/20/1996 | US5493019 Useful as antiinflammatory and antiproliferative agents |
| 02/20/1996 | US5492927 Non-peptide tachykinin receptor antagonists to treat allergy |
| 02/20/1996 | US5492906 Derivatives of thieno-triazolo-diazepine and therapeutic compositions containing them |
| 02/20/1996 | US5492314 Preloaded digressive rate mount |
| 02/20/1996 | CA2107110C Novel immunosuppressant agent from streptomyces braegensis |
| 02/20/1996 | CA1338078C Partial cationization of protein-containing antigens and method of immunization and desensitization |
| 02/20/1996 | CA1338077C Heterodimeric transforming growth factor-beta |
| 02/15/1996 | WO1996004388A1 Novel compounds |
| 02/15/1996 | WO1996004386A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 02/15/1996 | WO1996004314A1 Mhc complexes and uses thereof |
| 02/15/1996 | WO1996004280A1 Phenyl xanthine derivatives |
| 02/15/1996 | WO1996004266A2 Indol, indazol, pyridopyrrol and pyridopyrazol derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effects |
| 02/15/1996 | WO1996004263A1 Method for the preparation of (±)-calanolide a and intermediates thereof |
| 02/15/1996 | WO1996004250A1 Benzimidazole derivatives having dopaminergic activity |
| 02/15/1996 | WO1996003998A1 Quinoa saponin compositions and methods of use |
| 02/15/1996 | WO1996003982A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |
| 02/15/1996 | WO1996003876A1 Method for inhibiting nucleoside and nucleobase transport and virus replication in mammalian cells |
| 02/15/1996 | WO1995031991A3 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases |
| 02/15/1996 | DE3891231C2 Astigmatism correcting laser surgical set |
| 02/15/1996 | CA2196200A1 Novel compounds |
| 02/15/1996 | CA2196183A1 Azaaspartic acid analogs as interleukin-1 beta converting enzyme inhibitors |